Effect of neoadjuvant therapy pathway (NATP) for pancreatic cancer on overall patient outcomes. This is an ASCO Meeting Abstract from the 2023 ASCO Gastrointestinal Cancers Symposium. This abstract ...
Pancreatic enzyme replacement therapy (PERT) is the main treatment for exocrine pancreatic insufficiency (EPI). PERT replaces the digestive enzymes that the pancreas does not produce or release. EPI ...
Sepsis and pancreatic cancer: Biliary stents a significant risk factor in patients undergoing chemotherapy. This is an ASCO Meeting Abstract from the 2021 Gastrointestinal Cancers Symposium. This ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback